CTX0E03 Neural Stem Cells Modulate Inflammation for Psychiatric Disorders
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for psychiatric disorders such as depression and obsessive compulsive disorder are often ineffective, require long-term chronic treatment, and have significant side effects due to their impact on brain neurotransmitters and receptors, with a large population not responding to conventional drug therapy and experiencing delayed therapeutic benefits.
Innovation Solution
The use of the CTX0E03 neural stem cell line, which reduces and modulates pro-inflammatory cytokines, providing a safe and potent allogeneic treatment for psychiatric disorders by inhibiting immune system activation and inflammation, particularly for unipolar and bipolar depression, schizophrenia, obsessive compulsive disorder, and autism.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional anti-depressant drugs are used, then therapeutic benefit is achieved in some patients, but treatment requires long-term chronic administration and produces unwanted side effects
Solution Approach 1:
The patent uses neural stem cells as intermediary agents that mediate therapeutic effects through immunomodulation and neurogenesis rather than direct neurotransmitter modulation. The stem cells act as biological intermediaries that secrete trophic factors and regulate immune responses, providing therapeutic benefit without the direct receptor-based side effects of conventional drugs
Solution Approach 2:
The invention changes the fundamental therapeutic parameter from chemical neurotransmitter modulation to cellular immunomodulation and neurogenesis. By shifting from pharmacological parameter changes (receptor binding, neurotransmitter levels) to biological parameter changes (immune cell regulation, neuronal growth), the treatment achieves efficacy while avoiding drug-specific side effects
2Reliability
If conventional anti-depressant drugs are used, then some patients experience therapeutic benefit, but a large population does not respond to treatment
Solution Approach 1:
The neural stem cells possess multi-functional therapeutic mechanisms including immunomodulation, neurogenesis, and neuroprotection. This universality allows the treatment to address multiple pathological pathways simultaneously, making it applicable to diverse patient populations regardless of their specific neurotransmitter profiles or drug response patterns
3Reliability
If chronic anti-depressant treatment is administered, then cell proliferation and granule cell survival increase, but the treatment timeline is extended and tolerability decreases
Solution Approach 1:
The neural stem cells are administered in advance as a one-time intervention that initiates long-term neurogenic and immunomodulatory processes. The cells perform preliminary therapeutic action by establishing persistent populations of neurogenic cells and sustained immune regulation, eliminating the need for continuous chronic treatment and its associated latency and tolerability issues
Data Source
Figure 1A~1F
Figure 2A(i)~2B(iii)
Figure 3A~3B
AI summary
The present invention provides an isolated cell obtainable from the CTX0E03 neural stem cell line for use in the treatment of a disorder associated with elevated levels of pro-inflammatory cytokines, wherein the disorder is selected from unipolar and bipolar depression, schizophrenia, obsessive compulsive disorder, autism and autistic syndrome disorders.